adis.com Custom Intelligence Focus on your strategic decisions Learn More

Transcription

1 Custom Intelligence Focus on your strategic decisions Learn More

2 Focus on Your Strategic Decisions Rely on Adis, the company trusted worldwide for its drug, clinical trial, and adverse event databases, to provide the key information you need. Custom Intelligence from Adis is a flexible portfolio of solutions, each designed to provide the information and insights needed to answer some of the key questions facing the pharmaceutical industry. Whether you are looking for an easy way to view and track global drug pipelines, a comprehensive report detailing the implications of the current and potential future landscape on your drug, or a view of drug development across previous years to see which compounds and mechanisms of action were successful and which were not, Adis has the data and expertise to prepare the analysis on your behalf, allowing you to focus on interpreting the implications to make better decisions. Custom Intelligence projects are conducted in-house by qualified experts and analysts skilled at using Adis databases as well as publicly available resources to consolidate key information and communicate valuable insights. They tailor each project to meet your specific needs in order to enhance the quality of your decisions. Here are some examples of the projects we can work on for you 2

3 Rely on our expertise Trial Maps Visualize drug pipelines and clinical trial activity to assess the speed at which new treatments are coming to market. The Trial Map is a graphical representation of global clinical development effort for a specific indication, mechanism of action, company, and/or geographical region over a 10-year period. This concise view allows you to track competitors, identify key trials, monitor new spaces, and compare development activity across a selection of compounds at a glance. It also provides a means to compare and contrast the strategic paths each compound has taken including the time spent in each phase of development. Features include one-click drill-downs into the detailed drug development and clinical trial data in the AdisInsight databases plus predicted drug launch dates, global and regional revenue forecasts, expected phase changes, and estimated trial completion dates. Updates can also be set up to keep you informed of the latest news, development milestones, conference proceedings, and clinical trial activity. Dashboards Visualize drug pipelines and clinical trial activity to assess the speed at which new treatments are coming to market. Dashboard consoles can be used as a concise tracking tool to continually monitor the latest clinical and market developments for pipeline and marketed drugs. They allow you to quickly identify and assess competitive activity, licensing status, and company deals. Company profile can contain Summaries of ongoing trials Regulatory activity Published results from completed trials Development plans and timelines Tracking of subject recruitment for clinical studies Announcement of key trial results Changes in phase of development Approval by regulatory agencies Efficacy and tolerability data is added as it becomes available. From the dashboard it is possible to drill-down further into data in the AdisInsight databases without requiring a subscription. 3

4 Landscape Analysis Easily assess current and future products vying for market share and the catalysts indicating a change in the standard of care. The Landscape Analysis presents a comprehensive overview of current and future treatment practices for a specific indication, mechanism of action, company, and/or geographical region. It delivers a detailed understanding of the current standard of care, unmet clinical needs, the compounds that have the potential to change treatment practice, and the catalysts signaling a change in future treatment direction. Analyses draw upon the latest statistics and scientific data from Adis R&D Insight and Clinical Trials Insight databases as well as comprehensive literature searching. Epidemiology, patient demographics, risk factors and co-morbidities are included for your region of interest. Key attributes of current and future treatments including standard of care are also provided, SWOT analyses are performed and unmet needs are identified. Commentary or opinion from thought leaders and practicing health professionals can also be included. Conference Insight Monitor new scientific and promotional messages being communicated at medical meetings and conferences as they happen. Conference Insight uncovers cutting-edge intelligence through discussions with key opinion leaders, presenters, and even competitors that your in-house team may not be able to obtain. Our credentials as a global leader in scientific and medical publishing provide comprehensive access. The expert knowledge of our experienced medical writers delivers analysis and insight into developmental and marketed agents, trends in disease management and the scientific breakthroughs impacting your business. Each project is tailored to meet your specific needs Coverage can include A pre-meeting report highlighting relevant abstracts Attendance planning for specific presentations, poster sessions and booth activity Real-time and daily reports of breaking news Detailed post-meeting reports summarizing your area of interest 4

5 Longitudinal Pipeline Analysis Assess the time to market and associated risks for drugs in development. The Longitudinal Pipeline Analysis (LPA) provides a comprehensive snapshot of global drug development over the last 10 years spanning dozens of therapeutic areas and thousands of compounds. This comprehensive view over time allows you to compare drug development programs to see which compounds and mechanisms of action were successful and which were not. The LPA will aid in identifying high potential licensing and co-marketing opportunities, evaluating the probability of success, and contributes to the assessment of the R&D resources required to bring a new treatment to market. Additional Services Literature Monitoring Aggregated safety searches for PSUR reporting is just one example of our customized literature searching across multiple sources that we can tailor to meet your specific needs. Licensing Opportunity Report Identification of available or potential candidates including detailed summaries and SWOT analyses. Conference Highlights Reports Medical meeting reports written in absentia focused on your indication, drug or company of focus. 5 Custom AdisInsight Services Customized searches, feeds & charting from AdisInsight databases: R&D Insight, Clinical Trials Insight, and Pharmacovigilance Insight.

6 Custom Intelligence is brought to you by Adis, a leading provider of medical information worldwide. The AdisInsight suite of databases provide you with the tools to master the challenges of your business environment. R&D Insight A drug pipeline database that tracks and evaluates drugs worldwide through the entire development process, from discovery, through pre-clinical and clinical studies, to launch. It delivers a comprehensive combination of market and scientific drug development and innovation data. Visit for more information on Adis databases Pharmacovigilance Insight An easy-to-use database for pharmacovigilance literature monitoring. Updated daily, it gives you fast and reliable access to adverse drug reaction case reports, drug safety studies and regulatory news. Clinical Trials Insight A clinical trial and literature database providing coverage and evaluation of both ongoing trials and Best Evidence results presented at scientific conferences and published in scientific journals. Would you like to know more? Contact Springer today. Visit springer.com/salescontacts to find your local Springer representative! Contact us! A00083R / COR -59 A Images: Page 1: Lakov Kalinin / Shutterstock [m] Page 2: Nuiiko / Shuterstock [m], S. Dashkevych / Shutterstock, isak55 / Shutterstock Page 3: Denys Prykodov / Shutterstock, Matthew Jones / istockphoto Page 4: Elnur / Shutterstock Page 5: Dotshock / Shutterstock [m], Tsyhun / Shutterstock Page 6: Hongqi Zhang / Shutterstock